logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

KOS Corporation (02273.HK) issued a total of 2.8022 million new shares under the Restricted Share Award Plan.

date
01/12/2025
Wisdom Financial News APP News, Gushengtang (02273.HK) announced that on December 1, 2025, it issued 216,500 new shares to 121 eligible participants under the restricted stock award plan from the previous year.
Latest
1 m ago
He Yu-B (02256): The IND application for the orally administered small molecule KRAS G12D inhibitor ABSK141 has been approved by the FDA.
1 m ago
Yonggui Electronics: the company's holding subsidiary recently received a notification of winning a bid worth 17.89 million yuan.
2 m ago
New Asia Electronics: High frequency, high-speed copper cables have been supplied to Google data centers.
2 m ago
Mei Xinsheng: Wireless charging chips have been used in the DouBao AI phone.
2 m ago
HeYu Pharmaceutical: The IND application for the oral small molecule KRAS G12D inhibitor ABSK141 has been approved by the FDA.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.